Growing generic population across the globe is projected to fuel the growth of the global pharmaceutical desiccants market at a CAGR of 4.77% during the forecast period 2023 to 2030

Market Research Future (MRFR) has published on the “Global Pharmaceutical Desiccants Market”.

The global pharmaceutical desiccants market is accounted for to register a CAGR of 4.77% during the forecast period and is estimated to reach USD 1,44,840.70 thousand by 2030.

As the global population ages, the demand for medications and pharmaceutical products also increases. The elderly are more likely to require medications for various chronic conditions, leading to a higher consumption of pharmaceuticals. Pharmaceutical desiccants play a crucial role in maintaining the stability and efficacy of medications by reducing moisture levels in the packaging. With a growing population relying on medications for extended periods, the need to preserve the potency of drugs over longer shelf lives becomes more critical.

Many pharmaceutical products are sensitive to moisture and can degrade when exposed to high humidity levels. Desiccants help prevent moisture-related degradation, ensuring that drugs retain their effectiveness and safety throughout their shelf life.

The increasing demand for healthcare services in both developed and developing countries is driving the expansion of pharmaceutical manufacturing and distribution networks. This growth in the pharmaceutical industry further fuels the need for desiccants to ensure the quality of medications during storage and transportation.

As the population ages, the incidence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, also increases. These conditions often require long-term medication, leading to higher consumption of pharmaceutical products and greater reliance on desiccants for moisture control.

Regulatory bodies, such as the FDA and EMA, have stringent guidelines for pharmaceutical packaging and storage to ensure product safety and efficacy. The use of desiccants is often a regulatory requirement to meet quality standards, further driving their adoption in the pharmaceutical industry.

Improvements in healthcare infrastructure and access to medications in emerging markets are leading to a higher number of patients using pharmaceutical products. This expansion in patient populations drives the demand for desiccants to maintain medication quality and safety.

Key Players

MRFR recognizes the following companies as the key players in the global pharmaceutical desiccants market— E. I. Du Pont De Nemours and Company (US), Filtration Group Corporation (US), Sanner GmbH (Germany), Clariant Global (Switzerland), CSP Technologies Inc (US), Capitol Scientific Inc (US), Desiccare Inc (US), W. R. Grace & Company (US), Desican Inc (Canada), and Oker Chemie GmbH (Germany).

Segment Analysis

The global pharmaceutical desiccants market has been segmented based on type, end-use, and region.

The global pharmaceutical desiccants market segmentation, based on type has been segmented as silica gel, activated, carbonclay desiccant, molecular sieves. Among these, silica gel type is projected to dominate the global pharmaceutical desiccants market revenue through the projected period as estimated by MRFR analysts.

Silica gel has a high surface area and can adsorb moisture rapidly, making it a preferred choice for pharmaceutical applications. It helps prevent the degradation of moisture-sensitive medications by reducing humidity levels within the packaging, ensuring the drugs remain stable and effective. Silica gel is capable of adsorbing and retaining moisture over extended periods, making it ideal for pharmaceutical products with longer shelf lives or those that require transportation and storage in various environmental conditions.

The global pharmaceutical desiccants market segmentation, based on end-use has been segmented as tablets, API’s, capsules, and nutraceutical product packaging. Among these, tablets is projected to dominate the global pharmaceutical desiccants market revenue through the projected period as estimated by MRFR analysts.

Many pharmaceutical tablets are sensitive to moisture and can degrade when exposed to humidity. Moisture can affect the stability and efficacy of the active pharmaceutical ingredients (APIs) in the tablets. To ensure the quality and shelf life of moisture-sensitive tablets, pharmaceutical manufacturers use desiccants like silica gel to absorb any moisture that might be present in the packaging.

Tablets are often stored for extended periods before reaching the end-users. During this time, exposure to varying environmental conditions can lead to moisture absorption, potentially degrading the tablets. The use of desiccants helps to maintain the tablets' potency and extend their shelf life by minimizing moisture-related deterioration.

Regional Analysis

By Region, the study segments the Pharmaceutical Desiccants market into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The North America region has experienced significant economic growth over the past decades. North America is home to a thriving pharmaceutical industry, with numerous pharmaceutical companies, research institutions, and manufacturing facilities. The region's robust pharmaceutical sector drives the demand for pharmaceutical desiccants to ensure the stability and quality of medications during production, storage, and distribution.

North America is at the forefront of technological advancements in pharmaceutical manufacturing and packaging. As pharmaceutical companies in the region adopt state-of-the-art technologies and innovative packaging solutions, the use of desiccants becomes more prevalent to meet stringent quality standards and regulatory requirements.

Key Findings of the Study

• The global pharmaceutical desiccants market is expected to reach USD 1,44,840.70 thousand by 2030, at a CAGR of 4.77% during the forecast period.


• The North America region accounted for the fastest-growing global market.


• Based on type, the silica gel segment was attributed to holding the largest market in 2022.


• Based on end-use, the tablets segment was attributed to holding the largest market in 2022.


• I. Du Pont De Nemours and Company (US), Filtration Group Corporation (US), Sanner GmbH (Germany), Clariant Global (Switzerland), CSP Technologies Inc (US), Capitol Scientific Inc (US), Desiccare Inc (US), W. R. Grace & Company (US), Desican Inc (Canada), and Oker Chemie GmbH (Germany) are the key market players.